Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats
The FDA has placed MOTS-C in Category 2 of bulk drug substances for compounding, meaning there are noted safety risks that warrant restricted access
Why Choose Eskag Pharma for Liposomal Glutathione Capsules
Biles teammates Suni Lee, Grace McCallum, and Jordan Chiles finished out the competition, earning a silver medal for the United States
Activation of GLP-1R by liraglutide decreases apoptosis in chondrocytes To assess the role of GLP-1R in chondrocytes, we used liraglutide, a GLP-1R agonist, to activate GLP-1R with various concentrations
Efpeglenatide Efpeglenatide is a novel, long-acting GLP-1 receptor agonist developed by Hanmi Pharmaceuticals (South Korea) utilizing the proprietary LAPSCOVERY (Long-Acting Protein/Peptide Discovery) technology platform
